参考文献 [1]Liu F, Wei Y, Zhang H, Jiang J, Zhang P, Chu Q. NTRK Fusion in Non-Small Cell Lung Cancer: Diagnosis, Therapy, and TRK Inhibitor Resistance. Front Oncol. 2022 Mar 17;12:864666. [2]Farago AF...
Of these cases, 12 were positive for NTRK1 fusion, including 10 cases of adenocarcinoma (0.073%), 1 primary sarcomatoid carcinoma, and 1 with an unknown histologic classification. Seven fusion partners (CD74, interferon regulatory factor 2 binding protein 2 [1RF2BF2], lamin A/C [LMNA], ...
Wu P, Fang Y. Poor outcome in congenital mesoblastic nephroma with TPM3::NTRK1 fusion: a case report from multi-disciplinary treatment to molecular tumor board. Transl Pediatr. 2024 Jun 30;13(6):976-986. doi: 10.21037/tp-24-126. Epub 2024 Jun 27. PMID: 38984028; PMCID: PMC11228910....
- 参考文献- 1.Cocco E, Scaltriti M, Drilon A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol. 2018;15:731–47. 2.Okamura R, Boichard A, Kato S, Sicklick JK, Bazhenova L, Kur-zrock R. Analysis ...
Description TPM3, tropomyosin 3, is a member of the tropomyosin family of actin-interacting proteins, which regulates actin function and plays an essential role in embryonic development (PMID: 23904035, PMID: 26240174). TPM3-NTRK1 fusions are recurrent in colorectal cancer, and additional fusions ...
AI-Edigene® TFG(E5)-NTRK1(E10) Fusion询价产品描述 产品数据库CBP20139R Format RNA Description N/A Technical Data Left Gene TFG Left Breakpoint chr3:100451516:+ Right Gene NTRK1 Right Breakpoint chr1:156844363:+ Cosmic ID N/A Buffer RNase-free H2O ...
(Foundation Medicine Inc., Cambridge, MA, USA) to investigateNTRKgene fusions prevalence, co-occurrence with relevant biomarkers/oncogenic drivers, associated fusion partners and cancer types/histologies. Additionally,NTRKfusion-positive cases in the FoundationCORE database were compared with those ...
名称AI-Edigene® LMNA(E2)-NTRK1(E11) Fusion 型号CBP20173R 报价 特点AI-Edigene LMNA(E2)-NTRK1(E11) Fusion 详细内容 CBP20173R FormatRNA DescriptionN/A Technical Data Left GeneLMNA Left Breakpointchr1:156100564:+ Right GeneNTRK1 Right Breakpointchr1:156844698:+ ...
浅谈NTRK fusion 联系我们 联系人:蒋经理 电话:4008750250 号码: 手机:18066071954 地址:南京市栖霞区纬地路9号 Email: zhangxiangwen@cobioer.com 产品展示 / PRODUCTS 基因检测标准品 > Fusion > CBP20139RAI-Edigene® TFG(E5)-NTRK1(E10) Fusion ...
越来越多的医生将有能力让合适的患者在正确的时间获得匹配药物的治疗!并且随着国家和相关部门的重视,相信这些效果好的抗癌药都会加快在我国上市和纳入医保的步伐,让更多的百姓获益,我们共同期待! 参考资料: https://www.ajmc.com/view/diagnosis-and-management-of-trk-fusion-cancer 2. 备注【癌种】...